The Latest Breaking News from McKesson

McKesson earnings beat estimates, but the drug and health supplies distribution giant badly missed sales estimates.

Key economic data is on tap after Nvidia helped lead Wednesday's downside stock market reversal.

There are good reasons to invest in the long-term potential of these growth stocks.

Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement.

Author's Note: Sometimes a stock will come up continually on my screeners. MCK was featured 10/16/2023 when it was trading at $462.56. The stock has gained 30%+ since then. The Chart of the Day belongs to the healthcare medical distribution company McKesson (MCK) . I found the stock by using...

June S&P 500 E-Mini futures (ESM24) are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.02% this morning after three major U.S. benchmark indices ended the regular session higher as recent U.S. jobs data and remarks from Federal Reserve officials buoyed rate-cut hopes while investors awaited further…

Whistleblower lawsuit against McKesson revived over alleged illegal kickback schemes. Importance of transparency in healthcare industry highlighted.

Are you looking for probiotics to boost your emotional well-being? Explore our curated list of the top 13 mood probiotics known for enhancing digestion and promoting brain health.

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….